Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T20:33:10.135Z.
Calculation as of: 2026-10-06T20:33:10.135Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8cbf2c4bedb1eff0bddc45c0acac52f2eee77af7ab0e1536e55dbd1c791948ce
EARNINGS YIELD
N/A
Tarsus Pharmaceuticals, Inc.
Market Cap
$3.19B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.12B
Earnings Yield
N/A
TTM Avg
25.02%
3Y Avg
25.02%
5Y Avg
25.02%
Market Cap
$3.06B
Earnings Yield
N/A
TTM Avg
0.44%
3Y Avg
0.44%
5Y Avg
0.44%
Market Cap
$3.38B
Earnings Yield
11.25%
TTM Avg
8.17%
3Y Avg
6.43%
5Y Avg
6.43%
Market Cap
$2.99B
Earnings Yield
0.87%
TTM Avg
0.82%
3Y Avg
0.82%
5Y Avg
0.82%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | $3.19B | N/A | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.12B | N/A | 25.02% | 25.02% | 25.02% |
| CareDx, Inc (CDNA)vs › | $3.30B | 3.25% | 5.71% | 6.07% | 6.07% |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | N/A | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.06B | N/A | 0.44% | 0.44% | 0.44% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.03B | N/A | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | N/A | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 11.25% | 8.17% | 6.43% | 6.43% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $2.99B | 0.87% | 0.82% | 0.82% | 0.82% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
